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Abstract 
RAF oncogenes are involved in a variety of 
phenotypic switch phenomena. If for 
example oncogenic RAF is expressed 
together with Myc in B lineage cells, a 
lineage switch to macrophages occurs at low 
frequency in vitro and in vivo. In addition, if 
RAF is expressed in type II alveolar 
epithelial cells slow growing lung adenomas 
are formed and a switch from columnar to 
cuboidal cells is detected in these mice upon 
p53 deletion. A similar switch is also seen, if 
ectopic Myc is present in our lung tumor 
mouse model. Moreover, in the liver of these 
mice with both oncogenes metastases are 
found. If E-cadherin function is impaired in 
our RAF-dependent lung tumor model, a 
switch from adenoma to adenocarcinoma 
occurs and genes characteristic for the early 
endodermal lineage are expressed. Based on 
these data I propose a novel model of 
metastasis and describe its implications. The 
hallmark of the model is the induction of a 
state of plasticity in tumor cells, which 
allows the reversal of differentiation to an 
earlier point in their ontogenic history.  
 
 
Introduction 
Tumor metastasis is the leading cause of 
cancer death and consequently a major focus 
of research for more than 100 years. 
Although basic concepts such as the “seed 
and soil” hypothesis (Paget, 1889) or the 
idea that dissemination of metastases is 
predominantly determined by mechanical 
factors (Ewing, 1928) go back a long time, a 
deeper understanding of the molecular 
details of metastasis has only been gained 
recently (Fidler et al., 2002; Gupta and 
Massague, 2006; Eccles and Welch, 2007). 
For example, in the wake of the discovery of 
“dominant” oncogenes from viruses and 
transformed cells and insights into their 
generation by gain-of-function mutations, 
analogous strategies to those employed for 
oncogene isolation were used to identify 
metastasis genes (Nguyen and Massague, 
2007). In addition, metastasis suppressor 
genes blocking metastasis but not tumor 
formation (Steeg, 2003) and a “lung 
metastasis signature” with a set of genes 
mediating breast cancer metastasis 
specifically to the lung (Minn et al., 2005) 
have been identified. 
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Aberrant gene expression patterns and 
altered gene functions are key features of 
malignant progression and growing evidence 
now suggests that not only genetic but also 
epigenetic processes are causally involved in 
this deregulation (Jones and Baylin, 2007). 
Epigenetic mechanisms have also been 
considered as a driving force for malignant 
progression in the context of epithelial-
mesenchymal transition (EMT). EMT 
describes the process of reversible transition 
between tissue-bound epithelial and motile 
mesenchymal cells and is essential for 
several biological processes such as neural 
tube and mesoderm formation or wound 
healing (Thiery and Sleeman, 2006). 
Although EMT shares many phenotypic 
similarities with metastatic invasion its 
contribution to tumor progression is still 
controversial (Tarin et al., 2005; Hugo et al., 
2007). 
 Another line of evidence 
demonstrating the particular importance of 
epigenetic mechanisms for tumor 
progression comes from the discovery of 
oncogene-induced cellular plasticity 
(Principato et al., 1988; Nutt et al., 1999; 
Fedorov et al., 2003; Rawlins and Hogan, 
2006; Ceteci et al., 2007). These findings 
form the basis for the novel concept of 
metastatic conversion that is presented in 
this article. 
 
 
Experimental Background 
More than 30 years ago the induction of 
cellular plasticity or phenotypic instability 
by oncogenes was discovered in studies on 
co-operating oncogenes such as Myc and 
RAF that we have found to coexist in MH2, 
a particularly vicious carcinoma inducing 
avian retrovirus (Jansen et al., 1984). Myc 
and RAF act synergistically (see Fig. 1 and 
(Fedorov et al., 2003; Dominguez-Sola et al., 
2007), presumably because deleterious 
single oncogene effects cancel out each other 
in combination and because complementary 
steps in cell cycle progression are being 
activated. Moreover, both key aspects of 
carcinogenesis - initiation and promotion - 
are being perpetuated in double oncogene 
expressing cells. Whereas Myc is associated 
with genomic instability (Prochownik and 
Li, 2007) RAF is promoting survival and 
genomic stability.  
 The transformation of murine bone 
marrow cells with the J-2 retrovirus 
expressing v-raf/v-myc oncogenes yielded 
clonally related mature B cells and 
macrophages (Principato et al., 1988). 
Phenotypic analysis of these transformants 
revealed that mature myeloid cells were 
derived from cells with apparent B-lineage 
commitment and functional immunoglobulin 
rearrangement. This phenomenon was 
referred to as B-myeloid phenotypic switch 
and was the first evidence for the induction 
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of plasticity by a RAF/Myc combination (see 
Fig. 2).  
 To investigate whether this switch is 
a peculiarity of the hematopoietic system or 
whether it pertains also to epithelial tumors a 
mouse model for human lung cancer was 
developed by our group (Kerkhoff et al., 
2000). In this model, the expression of 
oncogenic RAF combined with the loss of 
the tumor suppressor p53 was shown to be 
associated with a switch in the phenotype of 
the target epithelial cell for transformation, 
in this case type II cuboidal pneumocytes, 
which turned into columnar, non-ciliated 
epithelial cells (Fedorov et al., 2003). 
Moreover, the latter population was 
characterized by a low level expression of 
ProSP-C surfactant protein C and of Clara 
cell antigen CC10 and may represent a 
progenitor pool for distal lung epithelial cells 
(see Fig. 2). 
 In a third example for a switch, 
oncogenic RAF was combined with the loss 
of another tumor suppressor gene, E-
cadherin, by either inducible gene ablation or 
by regulated expression of a dominant-
negative E-cadherin (Ceteci et al., 2007). In 
this most recent example tumor progression 
to micrometastasis was accompanied with 
expression of genes that are not typically 
expressed in type II pneumocytes but are 
reminiscent of the ontogenetic relationship 
of these cells with endoderm (Cardoso and 
Lu, 2006). A key regulator for these genes is 
ß-catenin that became activated as a 
consequence of induced E-cadherin 
dysfunction (Ceteci et al., 2007).  
 Finally, in ongoing work evaluating 
Myc/RAF oncogene cooperation in type II 
lung epithelial cells we again observed a 
phenotypic switch from cuboidal to 
columnar cells as already described in the 
combination of RAF with p53 loss (Rapp et 
al., in preparation). But in this case the 
switch was more frequent and correlated not 
only with tumor progression in the lung and 
micrometastasis but also with emergence of 
large metastases at distant sites such as the 
liver. These combined data were merged into 
a novel model for tumor progression to 
metastasis (see Fig. 3). 
 
The Model 
Lung-targeted expression of oncogenic RAF 
in type II alveolar epithelial cells leads to 
multiple slow growing and stable adenomas 
consisting of mature ProSP-C surfactant 
protein positive cells (Kerkhoff et al., 2000). 
When the function of E-cadherin was 
impaired in these mice by genetic means, ß-
catenin became activated and induced the 
expression of genes such as CDX2 and 
Atoh1 that are typical for cells of the 
endodermal lineage (Ceteci et al., 2007). I 
propose that a state of plasticity is induced 
in these lung tumor cells. This allows the 
reversal of differentiation to a point in their 
ontogenic history, at which endodermal 
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derivatives giving rise to liver (hepatoblasts) 
or to primordial lung are closely related and 
perhaps exchangeable. Upon evasion from 
the primary tumor site such circulating 
tumor cells home to the liver and switch 
their tissue dependence for growth from 
lung to liver. Our finding of micro-
metastases in the case of the dom.-neg. E-
cadherin/RAF combination may indicate 
that induction of a (committed) progenitor 
like phenotype is not frequent or stable 
enough to allow circulating tumor cells to 
form growing colonies. For this it might be 
necessary to reestablish cell adhesion via 
cadherins in the liver.  
 The overall scenario is different, 
when Myc is introduced instead of dom.-
neg. E-cadherin into the RAF expressing 
mice. Myc also promotes the reversal of 
differentiation. The resulting cells still retain 
cell-cell contacts, yet effectively form 
metastases in the liver, where they form 
large colonies (Rapp et al., in preparation). 
As there is no evidence for EMT the mode of 
cell migration in this case may be collective 
migration, i.e. migration of a cell cluster that 
remains connected by cell-cell junctions 
during movement for review see (Friedl et 
al., 2004). 
 What is the phenotype of liver 
metastases? Considering the proposed 
derivation from a (progenitor) subpopulation 
of the targeted alveolar epithelial cells in the 
primary tumor in which a (liver) stem cell-
like state was induced by the forced 
simultaneous expression of RAF and Myc 
oncogenes, it might have been expected that 
the cellular morphology differs from that in 
the primary tumor. However, this is clearly 
not the case and consequently the model 
postulates reversible hepatoblast mimicry 
that presumably is not followed by re-
differentiation to cuboidal, SP-C positive, 
CC10 negative type II cells due to a block to 
differentiation at the columnar cell stage 
mediated by constitutive Myc expression 
(Fig 3, C). A similar effect is seen in p53 
ablated constitutive RAF expressing type II 
cell derivatives in the lung (Fedorov et al., 
2003). 
 How early are liver colonizing lung 
tumor derived cells detectable? The size of 
liver metastases that we found at 10 months 
in Myc/RAF double transgenic mice 
suggests that lung tumor derived cells should 
have first arrived in the liver between 2 to 4 
months of age. Consistent with this 
estimation is the observation that 
subcutaneous injection of cells derived from 
the primary lung tumor at this age into 
immune-compromised mice lead to colonies 
in the liver that are similar to but also 
different from the primary tumor in that 
structures related to distal bronchioles are 
formed in addition to foci of columnar cells 
(Rapp et al., in preparation). This 
observation suggests that the metastasizing 
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columnar cells from the primary tumor have 
progenitor cell qualities. 
 In summary, the expression of 
plasticity inducing oncogenes in progenitor 
cells, such as the subpopulation of type II 
cells growing into foci in our RAF driven 
transgenic mouse model for NSCLC, induce 
gene expression profiles normally present in 
earlier progenitors thereby retracing 
ontogeny of the target cell. Reexpression of 
earlier programs in circulating tumor cells is 
thought to enable such cells to seed distant 
organs that have similar developmental roots 
such as liver in case of lung or colon tumor 
cells. 
 It is also conceivable that the 
emergence of early developmental programs 
in tumor cells will force such cells to leave 
the primary tumor site and to actively 
migrate to specific target organs that are 
developmentally related. Variations in signal 
intensity of plasticity inducing pathways are 
thought to be paralleled by reversal of 
dedifferentiation similar to reversal of 
induced plasticity in the course of tissue 
regeneration (Maurange et al., 2006) except 
if differentiation blocking oncogenes are 
constitutively expressed such as Myc or 
presumably mutant p53. Differentiation 
blocking oncogenes should convert 
reversible dedifferentiation linked to 
regeneration (as occurs in the lung for 
example after an infection with influenza 
virus) into a ratchet that accumulates 
increasingly more immature transformed 
progenitors with the number of rounds of 
challenges to regenerate. 
 
Predictions of the Model 
(1) Developmental gene expression 
signatures may predict targets of metastasis 
With respect to “metastasis signatures” in 
the primary tumor, the fraction of early 
progenitors or the size of the “cancer stem 
cell” compartment is predicted to be of 
highest prognostic value. Analyses of tumor 
biopsy material for early developmental 
markers of various derivatives of the same 
germ layer from which the tissue of the 
primary tumor originates may be particularly 
helpful, even if we assume that cells leave 
the primary tumor site simultaneously with 
the acquisition of metastatic ability. Another 
event that may signal progression to 
metastasis is the emergence of daughter 
colonies in the tissue of origin of the primary 
tumor. 
 
(2) Tumor progression is reflected by 
stepwise changes in gene expression patterns 
rather than overall chaotic transcription 
Reversal of ontogeny as opposed to the 
generation of “scrambled” phenotypes by 
plasticity inducing oncogenes is suggesting 
that the earliest detectable markers belong to 
the most recently suppressed programs. 
Although the available data on sequential 
changes in gene expression in differentiating 
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lineages of the major organ systems and in 
the process of transformation are limited, 
there is likely to be rapid progress in this 
area in the near future. 
 
(3) Phenotypic alterations of metastases at 
secondary sites may preclude their detection 
It is conceivable that some metastasizing 
cells will not reverse dedifferentiation after 
selective seeding at distant sites and instead 
will adopt phenotype(s) of the host tissue. If 
this is the case a second site tumor may not 
be recognized as a metastasis. Genetic 
models allowing lineage tracing will be most 
useful in evaluating this possibility. 
 
(4) Neo-formation of organ structures at 
secondary sites 
The fate of distant metastasis may not be 
limited to tumor evolution and instead 
induce ectopic formation of near normal 
structures such as alveolar ducts or cysts. 
 
(5) Lineage selector genes as novel 
therapeutic targets 
Under the assumption that lineage selector 
genes are usually not key regulatory 
molecules in the adult novel targets for 
therapeutic prevention or intervention should 
include lineage selector genes.  
(6) Genomic remodeling 
The complexity of mutations in metastases 
versus transplantable cancer (stem) cells is 
not necessarily increased. It will be of 
interest to see whether tetraploidisation by 
fusion or other mechanisms is more 
frequently found in metastases. 
 
(7) Plasticity induction and the ability of 
cancer stem cells to build niches 
The plasticity that is induced in founder cells 
of distant metastases may also operate in the 
building of niches. Therefore cells making 
up the microenvironment of the niche such 
as cells of the vasculature and other support 
cells including cells involved in tissue 
remodeling may be generated by the 
metastatic cell and therefore share genetic 
alterations. 
 
Outlook 
So far the observations on reprogramming of 
differentiated states in tumors have been 
limited by two factors: use of tissue-specific 
promoters for oncogene expression and lack 
of clonality markers. More mouse 
experiments need to be done with lineage 
tracers and conditional oncogene 
activation/expression that is independent of 
tissue-restricted promoters. These studies 
should be extended to experiments with 
purified cell populations. Transplantations 
should include adult animals as well as 
blastocyst injections. Human tumor samples, 
primary tumors and metastases need to be 
analyzed similarly in xenotransplantations. 
 Novel targets in oncogene bearing 
(transitional) progenitors for chemical and 
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immunological attack have to be identified. 
The mechanism of the oncogene-mediated 
differentiation block needs to be exploited 
for the development of differentiation 
inducing treatments, in addition to drugs 
impairing signaling pathways, which are 
involved in the generation of de-repressed 
chromatin states. 
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Fig. 1: The Balance Model: Cooperation between RAF and Myc Oncogenes. The relative expression/activity levels of RAF and Myc 
determine the cellular response with respect to proliferation, differentiation, senescence, apoptosis or survival. The preponderance of Myc 
induces genomic instability in early progenitor cells and a differentiation block, which might be followed by de-differentiation and/or apoptosis. 
Prevalence of RAF induces differentiation, late G1 arrest, senescence and survival in late progenitor cells and differentiated cells and promotes in 
general genomic stability. Equilibrium of Myc and RAF in progenitor cells results in proliferation. For more details see text and (Blasi et al., 
1985; Rapp et al., 1985; Rapp et al., 1994; Wilson et al., 2004). 
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Fig. 2:  In vitro and in vivo switch phenomena in hematopoietic and epithelial cell lineages involving the RAF oncogene.  
For more details see text. 
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Fig. 3: Model: Metastasis - A Recapitulation of Ontogeny. (A) The lung is of endodermal origin. Following gastrulation (at E7.5 in mice) the 
definitive endoderm give rise to the primitive gut tube, which later forms the thyroid, thymus, trachea, lung, liver and pancreas (Cardoso and Lu, 
2006). Primary lung bud and tracheal primordium formation is followed by secondary bud formation and branching morphogenesis, which results 
in the formation of the bronchial tree. Upon terminal differentiation the most distal region of the lung is organized into alveoli, where two types 
of epithelial cells are found: type I cells and cuboidal type II cells. (B) Induction of a state of plasticity, e.g. by the combination of targeted 
expression of oncogenic RAF in type II cells and E-cadherin impairment, allows reversal of differentiation of the type II cells to earlier points in 
their ontogenic history. This may lead to other lung cell types (1,2) or to cells mimicking the phenotype of cells from the primitive gut tube (3,4). 
Upon evasion from the primary tumor these cells home to tissues, which most closely resembles their phenotype, e.g. liver. Dedifferentiation is 
accompanied by a gain of novel potential metastatic targets and increase in malignancy of the tumor. (C) A differentiation block imposed by 
forced Myc expression or by p53 ablation (1) or by other factors (2) prevents redifferentiation and may further increase plasticity and 
heterogeneity of the transformed cell population. 
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